159 related articles for article (PubMed ID: 15476221)
1. Interferon-alpha-inducible proteins are novel autoantigens in murine lupus.
Hueber W; Zeng D; Strober S; Utz PJ
Arthritis Rheum; 2004 Oct; 50(10):3239-49. PubMed ID: 15476221
[TBL] [Abstract][Full Text] [Related]
2. Characterization of novel antigens recognized by serum autoantibodies from anti-CD1 TCR-transgenic lupus mice.
Hueber W; Zeng D; Sharpe O; Robinson WH; Strober S; Utz PJ
Eur J Immunol; 2004 Jun; 34(6):1654-62. PubMed ID: 15162435
[TBL] [Abstract][Full Text] [Related]
3. T cell autoimmunity in Ig transgenic mice.
Shinde S; Gee R; Santulli-Marotto S; Bockenstedt LK; Clarke SH; Mamula MJ
J Immunol; 1999 Jun; 162(12):7519-24. PubMed ID: 10358207
[TBL] [Abstract][Full Text] [Related]
4. Nucleolin as the earliest target molecule of autoantibodies produced in MRL/lpr lupus-prone mice.
Hirata D; Iwamoto M; Yoshio T; Okazaki H; Masuyama J; Mimori A; Minota S
Clin Immunol; 2000 Oct; 97(1):50-8. PubMed ID: 10998317
[TBL] [Abstract][Full Text] [Related]
5. Induction of nonpathologic, humoral autoimmunity in lupus-prone mice by a class II-restricted, transgenic alpha beta T cell. Separation of autoantigen-specific and -nonspecific help.
Peng SL; Fatenejad S; Craft J
J Immunol; 1996 Dec; 157(12):5225-30. PubMed ID: 8955166
[TBL] [Abstract][Full Text] [Related]
6. Ifi202, an IFN-inducible candidate gene for lupus susceptibility in NZB/W F1 mice, is a positive regulator for NF-kappaB activation in dendritic cells.
Yamauchi M; Hashimoto M; Ichiyama K; Yoshida R; Hanada T; Muta T; Komune S; Kobayashi T; Yoshimura A
Int Immunol; 2007 Aug; 19(8):935-42. PubMed ID: 17702989
[TBL] [Abstract][Full Text] [Related]
7. Treatment of murine lupus using nucleosomal T cell epitopes identified by bone marrow-derived dendritic cells.
Suen JL; Chuang YH; Tsai BY; Yau PM; Chiang BL
Arthritis Rheum; 2004 Oct; 50(10):3250-9. PubMed ID: 15476240
[TBL] [Abstract][Full Text] [Related]
8. Persistence of autoreactive T cell drive is required to elicit anti-chromatin antibodies in a murine model of drug-induced lupus.
Kretz-Rommel A; Rubin RL
J Immunol; 1999 Jan; 162(2):813-20. PubMed ID: 9916703
[TBL] [Abstract][Full Text] [Related]
9. Defects in the regulation of B cell apoptosis are required for the production of citrullinated peptide autoantibodies in mice.
López-Hoyos M; Marquina R; Tamayo E; González-Rojas J; Izui S; Merino R; Merino J
Arthritis Rheum; 2003 Aug; 48(8):2353-61. PubMed ID: 12905491
[TBL] [Abstract][Full Text] [Related]
10. Genomic view of IFN-alpha response in pre-autoimmune NZB/W and MRL/lpr mice.
Lu Q; Shen N; Li XM; Chen SL
Genes Immun; 2007 Oct; 8(7):590-603. PubMed ID: 17728792
[TBL] [Abstract][Full Text] [Related]
11. Genetic susceptibility to polyI:C-induced IFNalpha/beta-dependent accelerated disease in lupus-prone mice.
Jørgensen TN; Thurman J; Izui S; Falta MT; Metzger TE; Flannery SA; Kappler J; Marrack P; Kotzin BL
Genes Immun; 2006 Oct; 7(7):555-67. PubMed ID: 16900204
[TBL] [Abstract][Full Text] [Related]
12. Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis.
Kalaaji M; Sturfelt G; Mjelle JE; Nossent H; Rekvig OP
Arthritis Rheum; 2006 Mar; 54(3):914-26. PubMed ID: 16508974
[TBL] [Abstract][Full Text] [Related]
13. Analysis of MHC class II genes in the susceptibility to lupus in New Zealand mice.
Rozzo SJ; Vyse TJ; David CS; Palmer E; Izui S; Kotzin BL
J Immunol; 1999 Mar; 162(5):2623-30. PubMed ID: 10072504
[TBL] [Abstract][Full Text] [Related]
14. Identification of systemically expanded activated T cell clones in MRL/lpr and NZB/W F1 lupus model mice.
Zhou G; Fujio K; Sadakata A; Okamoto A; Yu R; Yamamoto K
Clin Exp Immunol; 2004 Jun; 136(3):448-55. PubMed ID: 15147346
[TBL] [Abstract][Full Text] [Related]
15. Influence of antigen organization on the development of lupus autoantibodies.
Fatenejad S; Bennett M; Moslehi J; Craft J
Arthritis Rheum; 1998 Apr; 41(4):603-12. PubMed ID: 9550469
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of interferon-activated gene 202 (Ifi202) correlates with the progression of autoimmune glomerulonephritis associated with the MRL chromosome 1.
Ichii O; Kamikawa A; Otsuka S; Hashimoto Y; Sasaki N; Endoh D; Kon Y
Lupus; 2010 Jul; 19(8):897-905. PubMed ID: 20167632
[TBL] [Abstract][Full Text] [Related]
17. Evidence for multiple mechanisms of polyclonal T cell activation in murine lupus.
Singh RR; Hahn BH; Tsao BP; Ebling FM
J Clin Invest; 1998 Nov; 102(10):1841-9. PubMed ID: 9819370
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 9 signaling protects against murine lupus.
Wu X; Peng SL
Arthritis Rheum; 2006 Jan; 54(1):336-42. PubMed ID: 16385525
[TBL] [Abstract][Full Text] [Related]
19. [Effects of HS1-associated protein X-1 on the lupus activities: experiment with MRL/lpr lupus-like mice].
Zhai ZF; Zhou CL; Zhong BY; Ao JH; Hao F
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):406-10. PubMed ID: 18581896
[TBL] [Abstract][Full Text] [Related]
20. Prevention and reversal of lupus in NZB/NZW mice by costimulatory blockade with adeno-associated virus-mediated gene transfer.
Ye X; Zhu T; Bastacky S; McHale T; Li J; Xiao X
Arthritis Rheum; 2005 Dec; 52(12):3975-86. PubMed ID: 16329128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
